Help us: Donate
Follow us on:
×

Tag: investment

September 09, 2020
In his presentation at Ending Age-Related Diseases 2020, investor Sergey Young discussed the potential of a trillion-dollar market, proactive versus reactive medicine, demographic changes throughout the world, technology integration, the potential of regenerative medicine, the role of capital in rejuvenation biotechnology, and many other related topics.
August 28, 2020
We're releasing the first of our videos from Ending Age-Related Diseases 2020, our successful two-day online conference that featured luminaries from the worlds of both rejuvenation biotechnology and investment. LEAF president Keith Comito opened the conference by giving a talk on the conference and its platform, the dangers of aging and what LEAF has been...
May 06, 2020
We had the opportunity to speak to Apollo Health Ventures about the Moonshot Venture Fellowship and about the aging research field in general from the perspective of a venture capital firm. Apollo Health Ventures is a life science venture capital firm and life science company builder working across Europe and North America. Apollo is unique...
November 01, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Sree Kant of Life Biosciences discussed investment and R&D in an aging world, demonstrating the necessity of rejuvenation biotechnology in...
October 28, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Joe Betts-LaCroix discussed the prioritization of aging compared to other government programs, the relationship between finance and human health, funding...
October 21, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. James Peyer of Kronos BioVentures gave a talk about the investment aspects of rejuvenation biotechnology, first explaining the effects of...